Completed NA INTERVENTIONAL 1-arm NCT05062135

Progesterone Action on Endometrium of PCOS

Abnormalities of the Endometrium Persist Despite Adequate Progesterone Supplementation in the Polycystic Ovary Syndrome

Sponsor: University of Sao Paulo General Hospital

Conditions Polycystic Ovary Progesterone Resistance

Interventions Progesterone 400 Mg Vaginal Suppository on PCOS

Updated 4 times since 2021 Last updated: Jan 4, 2022 Started: Feb 10, 2014 Primary completion: Sep 10, 2014 Completion: Apr 21, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Polycystic Ovary and Progesterone Resistance, this trial is completed. The trial is conducted by University of Sao Paulo General Hospital and has accumulated 4 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2022 — Jul 2024 [monthly]

Completed NA
Oct 2021 — Feb 2022 [monthly]

Completed NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Sao Paulo General Hospital

Data source: University of Sao Paulo General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.